Hopefully, DS will tell us when the first patient will be dosed and provide the est. costs of the trial. Also, since PAR has FDA approval, when will the U.S, sites be enrolling?
Also, how did their partnering trip to the U.S. go?
Ann: Paradigm to present at NWR Healthcare Conference, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.010(3.17%) |
Mkt cap ! $122.6M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 33.0¢ | 31.5¢ | $72.04K | 225.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 468 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 23283 | 3 |
View Market Depth
| Last trade - 10.22am 26/06/2025 (20 minute delay) ? |
| PAR (ASX) Chart |